Low Testosterone Levels and Metabolic Syndrome in Aging Male

Author(s): Rodrigo Blaya*, Patricia Blaya, Luiza Rhoden, Ernani Luis Rhoden

Journal Name: Current Pharmaceutical Design

Volume 23 , Issue 30 , 2017

Become EABM
Become Reviewer
Call for Editor


Advances in medicine and progressive improvements in the health of the general population in developed countries have led to considerable increases in life expectancy over recent years. Metabolic syndrome (MetS) affects approximately 25% of the adult population and its prevalence is increasing all over the world. Central obesity plays an important role in emergence of MetS. Some studies have suggested that there may be link between low Total Testosterone levels and emergence of MetS. The objective of this review is to analyze the complex network of interactions between MetS and low testosterone levels in elderly men, considering etiologic, diagnostic, and therapeutic aspects. Recent evidence confirms that central obesity is the independent MetS component correlated to Total Testosterone Levels. Experimental studies suggest a two way road between Low Testosterone Levels and abdominal obesity. Besides that, Testosterone Replacement Therapy should be restricted to men with biochemical and clinical features of late onset hypogonadism.

Keywords: Low testosterone, aging male, metabolic syndrome, hypogonadism, central obesity, testosterone replacement therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 28 November, 2017
Page: [4470 - 4474]
Pages: 5
DOI: 10.2174/1381612823666170503150955
Price: $65

Article Metrics

PDF: 47
HTML: 15
PRC: 2